The BCBS Settlement injunctive relief is worth gold to providers
Economists find that BCBS Settlement injunctive relief means more than $17.3 billion of value for providers. But only for those that don’t opt out.
BCBS settlement gives new visibility to BlueCard claims
The Blue Cross Blue Shield antitrust settlement is the gift that keeps on giving. But only to providers who stay in the settlement.
The risks of opting out of the landmark BCBS antitrust settlement
The Blue Cross Blue Shield antitrust settlement offers healthcare providers $2.8 billion in compensation and systemic BlueCard improvements, with opting out posing significant risks of costly, prolonged litigation and forfeiture of transformative benefits.
Beyond the payout: How the BCBS antitrust settlement will transform the BlueCard program for providers
The recent $2.8 billion Blue Cross Blue Shield antitrust settlement, coupled with mandated system improvements, promises to address long-standing issues with the BlueCard system, ensuring more timely payments, increased transparency, and reduced administrative burdens for healthcare providers.
New era of conflict with independent Blues?
Recently, we’ve seen an increase in conflict between independent Blues and the physicians and hospitals that populate their networks. What’s going on here?